US FDA requests removal of suicide warnings from weight-loss drug labels

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...

DEA, HHS extend telehealth controlled substance prescribing flexibilities for fourth time

The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...
MM&M

FDA’s updated RWE guidelines allow pharma marketers to make more claims

Prevailing regulations state that only “on-label” claims may be used by manufacturers in pharma advertising. A draft guidance released this week by the Food and Drug Administration, provides an ...
Medscape

Drug Labels Often Neglect to Inform About Obesity Dosing

Obesity can alter the action of many types of medications in ways affecting safety and/or efficacy, but this often isn’t mentioned in the labels. Experts in obesity and pharmacology are trying to ...
KSL

FDA requests removal of suicide warnings from weight-loss drug labels

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential ​risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli ...